Entia
Seedtable Score
37
Startups
1
Funding Rounds
2
Investors
$17.6m
Money raised
Overview
Entia addresses key pain points in the healthcare system by offering convenient and safe at-home blood testing for cancer patients. Traditional methods require travel to clinics or hospitals, which can be inconvenient and risky, potentially delaying crucial diagnostics. Entia’s platform minimizes these risks, enhances patient comfort, and allows for timely health monitoring. This unique value proposition makes it an attractive partner for healthcare providers, driving demand in the B2B market. Supported by investors like Business Growth Fund and Parkwalk Advisors, Entia is well-equipped to scale operations and leverage its innovative approach in the health tech sector.
- Website: https://entia.co
- Business model: b2b
- Company size: 11 - 51 employees
- Headquarters: London, UK
- Founded: 2014
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Entia has raised a total of $17.6m in funding over 1 rounds.
Key Insights:
- Series A: $17.6m
Entia Series A (2023, $17M)
$17.6m